Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-084-6 | CAS number: 68187-29-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 05 November 1986 to 28 November 1986
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Cross-reference
- Reason / purpose for cross-reference:
- other: Read-across target
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- For the justification for read-across, please refer to the read-across assessment framework report that is attached to Section 13.
- Reason / purpose for cross-reference:
- read-across source
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 - <= 10 000 mg/kg bw
- Based on:
- test mat.
- Interpretation of results:
- other: Not classified according to EU criteria.
- Conclusions:
- Under the conditions of the test, the acute oral LD50 was > 5.0 g/kg body weight and < 10.0 g/kg body weight.
- Executive summary:
The test material was administered once orally to mice in dosages of 5.0 g/kg, 10.0 g/kg and 20.0 g/kg.
Immediately after administration, a decrease in locomotor activity and diarrhoea were observed in the group that was administered 5.0 g/kg. One animal in this group died the second day after administration but the other 4 animals recovered. In the groups that were administered 10.0 g/kg and 20.0 g/kg, a decrease in locomotor activity, diarrhoea, and discharge of the substance administered from the naris were observed. In the group that was administered 20.0 g/kg, cyanosis, opisthotonus, and convulsions were also observed. Afterwards, all animals in the groups that were administered 10.0 g/kg and 20.0 g/kg died.
Based on the above, it was suggested, LD50 for this compound is greater than 5.0 g/kg body weight, less than 10.0 g/kg body weight.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The test material was administered once orally to 20 male mice in dosages of 5.0 g/kg, 10.0 g/kg and 20.0 g/kg. A volume of 0.67 mL of the sample to be administered per 10 g of body weight was orally administered to the animals into their stomachs using gastric catheters.
Clinical signs, mortality and body weight were assessed during the study and necropsies performed on all animals. - GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- TEA Lauroyl L-Glutamate
- IUPAC Name:
- TEA Lauroyl L-Glutamate
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Remarks:
- ICR (Crl: CD-1)
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 4 weeks oldon arrival, 5 weeks old at the time the test material was administered.
- Weight at study initiation: 25.2 to 29.3 g
- Fasting period before study: The animals were fasted for approximately 8 hours before administration. Feeding resumed 2 hours after administration.
- Housing: Polyethylene cages with 5 animals in each cage.
- Diet: Ad libitum
- Water: Ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23.3 ± 3 °C
- Humidity (%): 55 ± 5 %
- Air changes (per hr): 12 cycles per hour (all-fresh air system)
- Photoperiod (hrs dark / hrs light): 12 hours light:dark with light intensity of between 200 and 500 lx.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: The test material was dissolved in distilled water, and solutions of 7.5 %, 15.0 %, and 30.0 % were prepared immediately before administration.
MAXIMUM DOSE VOLUME APPLIED: 0.67 mL per 10 g of body weight was administered, representing that dosages of 5.0 g/kg, 10.0 g/kg, and 30.0 g/kg, of the test material were administered, respectively. - Doses:
- 5.0 g/kg, 10.0 g/kg, and 30.0 g/kg.
- No. of animals per sex per dose:
- 20 males
- Control animals:
- yes
- Remarks:
- The vehicle (distilled water)
- Details on study design:
- - Duration of observation period following administration: 8 days
- Frequency of observations and weighing: From the day of administration (Day 1) until Day 8, observations were made once a day as to whether there were any deaths of the animals. On Day 1, observation of acute toxicity symptoms was continuously conducted, starting immediately after administration for approximately 2 hours. Observation of clinical signs was also conducted on Day 1 before administration and once a day between Day 2 and Day 8.
The body weight of all surviving animals was measured on Days 1, 2, 6, and 8.
Dates were counted based on Day 1 being the day that administration was carried out.
- Necropsy of survivors performed: Yes
- Other examinations performed: Clinical signs, body weight,organ weights.
Results and discussion
Effect levels
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 - <= 10 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- During the study period, it was confirmed that upon orally administering the test material once to mice, there was 1 death on the 2nd day after administration (Day 3) in the group that was administered 5.0 g/kg. In addition, in the groups that were administered 10.0 g/kg and 20.0 g/kg, symptoms thought to be resulting from administration were observed immediately after administration, and all of the animals died.
- Clinical signs:
- other: Upon orally administering the test material once to mice, a decrease of locomotor activity and diarrohea were observed immediately after administration in the group that was administered 5.0 g/kg, and the death of 1 animal was confirmed on Day 3. The othe
- Gross pathology:
- Upon conducting necropsy examinations of the animals that died immediately after administration, haemorrhaging was found in the stomach or the intestinal tract of all animals, and there was also accumulation of water fluid in the intestinal tract. Upon conducting necropsy examinations of the surviving animals on the 7th day after administration, there were no abnormal findings for any of the animals.
Any other information on results incl. tables
Macroscopic findings
Dose (g/kg) |
Sex |
Animal No. |
Type of death |
Findings |
0 |
Male |
1 |
S |
- |
2 |
S |
- |
||
3 |
S |
- |
||
4 |
S |
- |
||
5 |
S |
- |
||
5.0 |
Male |
1 |
S |
- |
2 |
S |
- |
||
3 |
D2 |
C |
||
4 |
S |
- |
||
5 |
S |
- |
||
10.0 |
Male |
1 |
D1 |
A,B |
2 |
D1 |
A,B |
||
3 |
D1 |
A,B |
||
4 |
D1 |
A,B |
||
5 |
D1 |
A,B |
||
20.0 |
Male |
1 |
D1 |
A,B |
2 |
D1 |
A,B |
||
3 |
D1 |
A,B |
||
4 |
D1 |
A,B |
||
5 |
D1 |
A,B |
-: No abnormal findings,
A: Water fluid and haemorrhage in intestine
B: Dehydration (abdominal cavity)
C: No significant gross pathological findings were recorded because of the severe post-mortem change
Type of death:
S: Scheduled
D1: Death (Day 1)
D2: Death (Day 3)
Applicant's summary and conclusion
- Interpretation of results:
- other: Not classified according to EU criteria.
- Conclusions:
- Under the conditions of the test, the acute oral LD50 was > 5.0 g/kg body weight and < 10.0 g/kg body weight.
- Executive summary:
The test material was administered once orally to mice in dosages of 5.0 g/kg, 10.0 g/kg and 20.0 g/kg.
Immediately after administration, a decrease in locomotor activity and diarrhoea were observed in the group that was administered 5.0 g/kg. One animal in this group died the second day after administration but the other 4 animals recovered. In the groups that were administered 10.0 g/kg and 20.0 g/kg, a decrease in locomotor activity, diarrhoea, and discharge of the substance administered from the naris were observed. In the group that was administered 20.0 g/kg, cyanosis, opisthotonus, and convulsions were also observed. Afterwards, all animals in the groups that were administered 10.0 g/kg and 20.0 g/kg died.
Based on the above, it was suggested, LD50 for this compound is greater than 5.0 g/kg body weight, less than 10.0 g/kg body weight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.